Stage at diagnosis only partly explains wide international variation in lung cancer survival
Stage at diagnosis only partly explains the wide variation in lung cancer survival rates among different developed countries, indicates a large study of nearly 60,000 patients, published online in Thorax.
Other factors, such as treatment, are also likely to have a key role, say the authors.
Stage at diagnosis has often been suggested as one of the primary reasons why lung cancer survival is low in certain countries, such the UK, on the grounds that patients go to see their doctors too late for treatment to be effective.
The authors collected information on more than 57,000 adults diagnosed with primary lung cancer between 2004 and 2007 whose details had been entered in regional or national cancer registries in one of six countries.
These were Australia; Canada; Denmark; Norway; Sweden; and the UK. The authors then looked at data on how advanced the tumour was at diagnosis, with stage classified from early to late (I-IV) under the international TNM scheme.
They then monitored all the patients in order to estimate survival at one year and 18 months after diagnosis, for each diagnostic stage, for both non-small cell lung cancer and small cell lung cancer.
Non-small cell lung cancer accounts for 80% of all lung cancers. It grows more slowly and is generally more responsive to treatment. Small cell lung cancer tends to be more aggressive.
International comparisons of survival were adjusted to take account of differences in age and death from other causes.
Men made up between 52% (Sweden) and 62% (Australia) of the patients, and the average age at diagnosis was 70. The UK had the highest proportion of patients for whom data on stage were missing.
The analyses showed wide differences in overall survival one year after diagnosis. After taking account of age, this varied from 30% in the UK to 46% in Sweden. Survival was also high in Australia and Canada (42%) and intermediate in Denmark (34%) and Norway (39%).
One year survival for patients with small cell lung cancer was 12-16% lower in the UK than in Sweden and Australia, and intermediate elsewhere.
There were also international survival differences at each stage of diagnosis, but the UK had the lowest survival at each stage of disease for both types of lung cancer.
Sweden had the highest. Denmark had low survival for early stage disease, but average survival for more advanced disease. And Canada had comparatively high survival for early disease but not for more advanced disease.
Differences in the pattern of disease, delays in diagnosis or in the accuracy of investigations for each stage may account for some of the differences in survival, say the authors.
"Low stage-specific survival in the UK could conceivably arise in part because of suboptimal staging, and this misclassification of stage in a proportion of patients could lead to inappropriate treatment and therefore overall lower survival," they write.
But other factors, including differences in the quality of, and access to, treatment, are also likely to have a role, they say.
"This study demonstrates wide differences between six wealthy countries in short-term survival from lung cancer, the most common cause of cancer death worldwide," they write.
There are no obvious explanations for these variations, they write, and differences in diagnostic staging and treatment are likely to have a key role, they conclude.
More information: doi 10.1136/thoraxjnl-2012-202297
Journal reference: Thorax
Provided by British Medical Journal
- Differences in treatment for advanced ovarian cancer could explain why UK survival lags behind other countries Oct 04, 2012 | not rated yet | 0
- Lung cancer patients who quit smoking double their survival chances Jan 21, 2010 | not rated yet | 0
- Twice as many Swedes as Brits survive lung cancer Apr 29, 2010 | not rated yet | 0
- Patients' pretreatment quality of life can predict overall lung cancer survival Sep 02, 2009 | not rated yet | 0
- Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC Apr 04, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer May 24, 2013 | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer May 24, 2013 | 5 / 5 (1) | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer May 24, 2013 | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer May 24, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer May 24, 2013 | 5 / 5 (4) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
21 hours ago | 5 / 5 (6) | 5
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
21 hours ago | 5 / 5 (1) | 1
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
13 hours ago | not rated yet | 1
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
May 20, 2013 | 4.8 / 5 (31) | 9 |
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
May 22, 2013 | 4.3 / 5 (6) | 6 |
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
21 hours ago | not rated yet | 0